Á lódáil...
Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas
The Epstein-Barr virus (EBV) is one of the predominant tumor viruses in humans, but so far no therapeutic or prophylactic vaccination against this transforming pathogen is available. We demonstrated that heterologous prime-boost vaccination with the nuclear antigen 1 of EBV (EBNA1), either targeted...
Na minha lista:
| Foilsithe in: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
American Society for Clinical Investigation
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486346/ https://ncbi.nlm.nih.gov/pubmed/31042161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI125364 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|